Others

Ajanta Pharma Ltd. - Announcement under Regulation 30 (LODR)-Investor Presentation

| Updated on July 31, 2018 Published on July 31, 2018

We refer to the Unaudited financial results for the third quarter ended 30th June, 2018 submitted to your office today.

Pursuant to Regulation 46 SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are now attaching the presentation on results being circulated to the investors and analysts and uploaded on our website.

Kindly take the same on your records and disseminate to your members.

Pdf Link: Ajanta Pharma Ltd. - Announcement under Regulation 30 (LODR)-Investor Presentation

Source : BSE - www.bseindia.com

Published on July 31, 2018
This article is closed for comments.
Please Email the Editor